CAPTOPRIL - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for captopril and what is the scope of patent protection?
Captopril
is the generic ingredient in seven branded drugs marketed by Strides Pharma, Ajanta Pharma Ltd, Andas 5 Holding, Apothecon, Aurobindo Pharma Usa, Changzhou Pharm, Chartwell Rx, Corepharma, Cosette, Dava Pharms Inc, Egis Pharms, G And W Labs Inc, Hikma Intl Pharms, Oxford Pharms, Prinston Inc, Purepac Pharm, Sandoz, Seton Pharms, Teva, Watson Labs, Wockhardt, Ivax Sub Teva Pharms, and Rising, and is included in thirty-three NDAs. Additional information is available in the individual branded drug profile pages.There are fifteen drug master file entries for captopril. Thirteen suppliers are listed for this compound.
Summary for CAPTOPRIL
US Patents: | 0 |
Tradenames: | 7 |
Applicants: | 23 |
NDAs: | 33 |
Drug Master File Entries: | 15 |
Finished Product Suppliers / Packagers: | 13 |
Raw Ingredient (Bulk) Api Vendors: | 118 |
Clinical Trials: | 50 |
Patent Applications: | 6,348 |
Drug Prices: | Drug price trends for CAPTOPRIL |
What excipients (inactive ingredients) are in CAPTOPRIL? | CAPTOPRIL excipients list |
DailyMed Link: | CAPTOPRIL at DailyMed |
Recent Clinical Trials for CAPTOPRIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Natural Wellness Egypt | Phase 3 |
Shanghai Jiao Tong University School of Medicine | Phase 4 |
Iain Bressendorff | Phase 2 |
Pharmacology for CAPTOPRIL
Drug Class | Angiotensin Converting Enzyme Inhibitor |
Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Medical Subject Heading (MeSH) Categories for CAPTOPRIL
Anatomical Therapeutic Chemical (ATC) Classes for CAPTOPRIL
US Patents and Regulatory Information for CAPTOPRIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Purepac Pharm | CAPTOPRIL | captopril | TABLET;ORAL | 074640-001 | Mar 31, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Corepharma | CAPTOPRIL | captopril | TABLET;ORAL | 074737-001 | Oct 28, 1998 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hikma Intl Pharms | CAPTOPRIL | captopril | TABLET;ORAL | 074505-002 | Feb 13, 1996 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Changzhou Pharm | CAPTOPRIL | captopril | TABLET;ORAL | 214442-001 | Jan 27, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CAPTOPRIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-005 | Jan 17, 1985 | ⤷ Sign Up | ⤷ Sign Up |
Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Strides Pharma | CAPOTEN | captopril | TABLET;ORAL | 018343-004 | Jun 13, 1995 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.